We use cookies for a better user experience. Read our Privacy Policy
I Agree
Anal Fistula Treatment Market
Anal Fistula Treatment Market - Snapshot
Anal fistula is a tunnel or tract between the epithelial surface of the rectum or anus and the skin i.e., perianal area. This tract can develop infection causing swelling, pus, and pain. The global anal fistula treatment market was valued at US$ 550 Mn in 2017 and is anticipated to expand at a CAGR of 4% from 2018 to 2026 to reach US$ 800 Mn by 2026. High incidence rate of anal fistula and recurrence rate of treated cases have led to a large patient pool. Moreover, increase in incidence of anal fistula inducing co-morbidities such as Crohn’s disease, anal abscess, HIV, and TB infections have resulted in new complex anal fistula cases. Rise in demand for safe and effective treatment with no chance of recurrence and fewer side effects is inducing key industry players to introduce advanced drugs and devices. These include under trial collagen paste for blocking and removing fistula tract, adipose stem cell therapy for anal fistula treatment in Crohn’s disease, video-assisted anal fistula treatment (VAAFT) devices, and laser energy-based devices for anal fistula. However, high cost of treatment and lack of awareness about anal fistula treatment are likely to restrain the global anal fistula treatment market during the forecast period.
High unmet needs in the global anal fistula treatment market present lucrative opportunities for existing players and new entrants. Examples of recent developments in the field are anal fistula tool comprising a channel for anal fistula treatment Queen Mary University of London, by January 2018, Implantable prosthesis for anal fistula treatment by C.R. Bard (acquired by BD) in February 2018, Seton stringing device for anal fistula treatment by Changshu No.2 People’s Hospital in June 2017, innovation of elastic thread for drawing thread in perianal abscess and anal fistula treatment by First Affiliated Hospital of Jiaoning University of Traditional Chinese Medicine in June 2017 and others.
In terms of treatment type, the global anal fistula treatment market has been segmented into surgical and non-surgical. The non-surgical segment has been bifurcated into drugs and others. The surgical segment has been classified into fistulotomy, advancement flap procedures, seton techniques, bioprosthetic plugs, and others. Based on application, the global market can be divided into intersphincteric, transsphincteric, suprasphincteric, extrasphincteric, and others. In terms of end-user, the global anal fistula treatment market can be classified into hospitals & ambulatory surgery centers, clinics, and others.
North America accounted for the largest share of the global anal fistula treatment market in 2017, followed by Europe. North America’s dominance of the global market is due to early adoption of new technologies and high health care expenditure by the public and private sectors in the U.S. Growth of the anal fistula treatment market in the country is also attributed to high prevalence of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. According to the Crohn’s & Colitis Foundation of America (CCFA), nearly 1.6 million people in the U.S. had IBD in 2014, which includes 780,000 people with Crohn’s disease and 907,000 with ulcerative colitis. Approximately 70,000 new cases of IBD are diagnosed in the country each year. It is estimated that around 35% people with Crohn’s disease develop anal fistula. On the other hand, key players prefer to introduce new treatment tools in Europe. For instance, TiGenix & Takeda Pharmaceutical introduced adipose stem cell-based therapy in March 2018. Medtronic plc is conducting trials for its collagen paste Permacol in Europe. New product launches and their adoption are likely to fuel the market in the region.
The anal fistula treatment market in Asia Pacific is set to grow at a rapid pace during the forecast period. Developing economies such as China, India, and countries in Southeast Asia are likely to contribute to the growth of the market in Asia Pacific from 2018 to 2026. Initiatives to improve health care infrastructure, increase in health care expenditure, and trend of medical tourism in these countries are projected to boost the market in Asia Pacific. Moreover, rise in new cases of anal fistula among men in Brazil, increase in awareness about the condition, and high rate of diagnosis and treatment are likely to propel the market in the country during the forecast period. A study conducted at the Hospital Santa Izabel, Brazil, and published in ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA in 2014, stated that video-assisted fistulotomy proved to be safe and effective in the treatment of anal fistula. This procedure helped directly visualize the internal openings, allowing surgeons to operate without any risk of mistakes. Such technological advancements are projected to augment the anal fistula treatment market in Brazil from 2018 to 2026. Low awareness about anal fistula treatment and inadequate medical infrastructure in Africa are likely to restrain the anal fistula treatment market in Middle East & Africa during the forecast period.
Key companies operating in the global anal fistula treatment market are Becton, Dickinson and Company, biolitec AG, Cook Medical, Gem srl, KARL STORZ SE & Co. KG, Medtronic plc, TiGenix NV, and W. L. Gore & Associates, Inc. (Gore Medical).
Technological Progress to Foster Growth of the Anal Fistula Treatment Market
Anal fistula refers to a tract or tunnel between epithelial surface of the anus or rectum and the skin i.e. the perianal space. This tunnel is able to cause infection causing pain, pus, and swelling. The global anal fistula treatment market is expected to exhibit rapid growth owing to increasing incidences of different inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. In addition, launch of various new products along with rising demand for various non-surgical methods, such as adipose-derived stem cells therapy, fibrin glue injection are estimated to trigger growth of the global anal fistula treatment market in the years to come. In addition, there has been surging incidences of anal fistula because it is still quite a complicated condition for the surgeons.
Increased prevalence of inflammatory bowel disease and rise in incidences of AIDS (acquired immunodeficiency syndrome) are expected to emerge as growth factors for the global anal fistula treatment market in the years to come.
Increased Preference for Surgeries for Treatment to Boost Demand in the Market
In an effort to ensure good quality of life and low rate of recurrence is expected to drive the demand for surgical treatment. Surgical treatment is highly dependent on the position of fistula. Surgeries are also dependent on whether the fistula is branched off or is a single channel. Various surgical procedures comprise seton techniques, advancement flap procedures, bioprosthetic plugs, and fistulotomy. It also comprises new techniques, such as FiLaC therapy and LIFT therapy. Fistulotomy is the most common type of surgery of anal fistules.
When it comes to treatment of anal fistula, surgeries are the most common method. There has been rising cases of infections caused by fistula along with the growing demand for effective and safe method treatment is likely to widen the scope of the global anal fistula treatment market in the near future. Fewer side effects and reduced chances of recurrence are estimated to encourage industry players to come up with new devices and drugs. Such developments comprise an under trial paste of collagen utilized for removing and blocking fistula tract, laser energy-based devices for anal fistula, and video-assisted anal fistula treatment (VAAFT) devices.
The global anal fistula treatment market has been segmented as follows:
|
Treatment Type |
|
|
Application |
|
|
End-user |
|
|
Region |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anal Fistula Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anal Fistula Treatment Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Price Comparison Analysis (2017)
5.1.1. By Treatment Type
5.1.2. By Region
5.2.Regulatory Scenario by Region/globally
5.3.Key Mergers & Acquisitions
5.4.Disease Prevalence & Incidence Rate, by Region
5.5.Reimbursement Scenario: Anal Fistula Treatment
5.6.Technological Advancements
6. Global Anal Fistula Treatment Market Analysis and Forecasts, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2016–2026
6.3.1. Non-surgical
6.3.1.1. Drugs
6.3.1.2. Others
6.3.2. Surgical
6.3.2.1. Fistulotomy
6.3.2.2. Bioprosthetic Plugs
6.3.2.3. Seton Techniques
6.3.2.4. Advancement Flap Procedures
6.3.2.5. Others
6.4. Market Attractiveness, by Treatment Type
7. Global Anal Fistula Treatment Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2016–2026
7.3.1. Intersphincteric
7.3.2. Transsphincteric
7.3.3. Suprasphincteric
7.3.4. Extrasphincteric
7.3.5. Others
7.4. Market Attractiveness, by Application
8. Global Anal Fistula Treatment Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Anal Fistula Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Anal Fistula Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2016–2026
10.2.1. Non-surgical
10.2.1.1. Drugs
10.2.1.2. Others
10.2.2. Surgical
10.2.2.1. Fistulotomy
10.2.2.2. Bioprosthetic Plugs
10.2.2.3. Seton Techniques
10.2.2.4. Advancement Flap Procedures
10.2.2.5. Others
10.3. Market Value Forecast, by Application, 2016–2026
10.3.1. Intersphincteric
10.3.2. Transsphincteric
10.3.3. Suprasphincteric
10.3.4. Extrasphincteric
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Anal Fistula Treatment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Treatment Type, 2016–2026
11.2.1. Non-surgical
11.2.1.1. Drugs
11.2.1.2. Others
11.2.2. Surgical
11.2.2.1. Fistulotomy
11.2.2.2. Bioprosthetic Plugs
11.2.2.3. Seton Techniques
11.2.2.4. Advancement Flap Procedures
11.2.2.5. Others
11.3.Market Value Forecast, by Application, 2016–2026
11.3.1. Intersphincteric
11.3.2. Transsphincteric
11.3.3. Suprasphincteric
11.3.4. Extrasphincteric
11.3.5. Others
11.4.Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.2. Clinics
11.4.3. Others
11.5.Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Anal Fistula Treatment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Treatment Type, 2016–2026
12.2.1. Non-surgical
12.2.1.1. Drugs
12.2.1.2. Others
12.2.2. Surgical
12.2.2.1. Fistulotomy
12.2.2.2. Bioprosthetic Plugs
12.2.2.3. Seton Techniques
12.2.2.4. Advancement Flap Procedures
12.2.2.5. Others
12.3.Market Value Forecast, by Application, 2016–2026
12.3.1. Intersphincteric
12.3.2. Transsphincteric
12.3.3. Suprasphincteric
12.3.4. Extrasphincteric
12.3.5. Others
12.4.Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Clinics
12.4.3. Others
12.5.Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Anal Fistula Treatment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Treatment Type, 2016–2026
13.2.1. Non-surgical
13.2.1.1. Drugs
13.2.1.2. Others
13.2.2. Surgical
13.2.2.1. Fistulotomy
13.2.2.2. Bioprosthetic Plugs
13.2.2.3. Seton Techniques
13.2.2.4. Advancement Flap Procedures
13.2.2.5. Others
13.3.Market Value Forecast, by Application, 2016–2026
13.3.1. Intersphincteric
13.3.2. Transsphincteric
13.3.3. Suprasphincteric
13.3.4. Extrasphincteric
13.3.5. Others
13.4.Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Clinics
13.4.3. Others
13.5.Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Anal Fistula Treatment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Treatment Type, 2016–2026
14.2.1. Non-surgical
14.2.1.1. Drugs
14.2.1.2. Others
14.2.2. Surgical
14.2.2.1. Fistulotomy
14.2.2.2. Bioprosthetic Plugs
14.2.2.3. Seton Techniques
14.2.2.4. Advancement Flap Procedures
14.2.2.5. Others
14.3.Market Value Forecast, by Application, 2016–2026
14.3.1. Intersphincteric
14.3.2. Transsphincteric
14.3.3. Suprasphincteric
14.3.4. Extrasphincteric
14.3.5. Others
14.4.Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospitals & Ambulatory Surgical Centers
14.4.2. Clinics
14.4.3. Others
14.5.Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1.Market Footprint Analysis
15.1.1. By Region
15.1.2. By Treatment Type
15.2. Competitive Business Strategies
15.3. Company Profiles
15.3.1. Becton, Dickinson and Company
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Business Overview
15.3.1.3. Product Portfolio
15.3.1.4. Financial Overview
15.3.1.5. SWOT Analysis
15.3.1.6. Strategic Overview
15.3.2. biolitec AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Business Overview
15.3.2.3. Product Portfolio
15.3.2.4. Financial Overview
15.3.2.5. SWOT Analysis
15.3.2.6. Strategic Overview
15.3.3. Cook Medical
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Business Overview
15.3.3.3. Product Portfolio
15.3.3.4. Financial Overview
15.3.3.5. SWOT Analysis
15.3.3.6. Strategic Overview
15.3.4. Gem srl
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Business Overview
15.3.4.3. Product Portfolio
15.3.4.4. Financial Overview
15.3.4.5. SWOT Analysis
15.3.4.6. Strategic Overview
15.3.5. KARL STORZ SE & Co. KG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Business Overview
15.3.5.3. Product Portfolio
15.3.5.4. Financial Overview
15.3.5.5. SWOT Analysis
15.3.5.6. Strategic Overview
15.3.6. Medtronic plc
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
15.3.6. TiGenix NV
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
15.3.6. W. L. Gore & Associates, Inc. (Gore Medical)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
List of Tables
Table 01: Key Mergers/Acquisitions/Collaborations
Table 02: Technological Advancements
Table 03: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 04: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type (Non-surgical), 2016–2026
Table 05: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type (Surgical), 2016–2026
Table 06: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 07: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 08: Global Anal Fistula Treatment Market (US$ Mn) Forecast, by Region, 2016–2026
Table 09: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 10: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 11: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical Treatment, 2016–2026
Table 12: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2016–2026
Table 13: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 14: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 17: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical Treatment, 2016–2026
Table 18: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2016–2026
Table 19: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 20: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 23: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical Treatment, 2016–2026
Table 24: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2016–2026
Table 25: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 26: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 27: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 28: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 29: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical, 2016–2026
Table 30: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical, 2016–2026
Table 31: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 32: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 33: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 34: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 35: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical, 2016–2026
Table 36: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical, 2016–2026
Table 37: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 38: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 39: Key Player’s Market Footprints, by Region
Table 40: Key Player’s Market Footprints, by Region
List of Figures
Figure 01: Global Anal Fistula Treatment Market Size (US$ Mn) and Distribution by Region, 2017 and 2026
Figure 02: Global Anal Fistula Treatment
Figure 03: Top 3 Trends
Figure 04: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 05: Global Market Value Share, by Treatment Type (2017)
Figure 06: Global Market Value Share, by Application (2017)
Figure 07: Global Market Value Share, by End-user (2017)
Figure 08: Global Market Value Share, by Region (2017)
Figure 09: Pricing Analysis, by Surgical Treatment
Figure 10: Pricing Analysis, by Region (Surgical Treatment)
Figure 11: Anal Fistula Prevalence, by Region (2017)
Figure 12: Anal Fistula Prevalence, by Region (2017)
Figure 13: Global Anal Fistula Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 14: Global Anal Fistula Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 15: Global Anal Fistula Treatment Market Value Share, by Treatment Type (Non-surgical), 2017 and 2026
Figure 16: Global Anal Fistula Treatment Market Attractiveness, by Treatment Type (Surgical), 2017 and 2026
Figure 17: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2016–2026
Figure 18: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 19: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fistulotomy, 2016–2026
Figure 20: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bioprosthetic Plugs, 2016–2026
Figure 21: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Seton Techniques, 2016–2026
Figure 22: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Advancement Flap Procedures, 2016–2026
Figure 23: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 24: Global Anal Fistula Treatment Market Attractiveness, by Treatment Type (Non-surgical), 2018–2026
Figure 25: Global Anal Fistula Treatment Market Attractiveness, by Treatment Type (Surgical), 2018–2026
Figure 26: Global Anal Fistula Treatment Market Value Share, by Application, 2017 and 2026
Figure 27: Global Anal Fistula Treatment Market Attractiveness, by Application, 2018–2026
Figure 28: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Intersphincteric, 2016–2026
Figure 29: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Transsphincteric, 2016–2026
Figure 30: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Suprasphincteric, 2016–2026
Figure 31: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Extrasphincteric, 2016–2026
Figure 32: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2016–2026
Figure 33: Global Anal Fistula Treatment Market Value Share, by End-user, 2017 and 2026
Figure 34: Global Anal Fistula Treatment Market Attractiveness, by End-user, 2018–2026
Figure 35: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & ASCs, 2016–2026
Figure 36: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Clinics, 2016–2026
Figure 37: Global Anal Fistula Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other End-user, 2016–2026
Figure 38: Global Anal Fistula Treatment Market Scenario, by Country / Sub-region
Figure 39: Global Anal Fistula Treatment Market Analysis, by Region, 2017 and 2026
Figure 40: Global Anal Fistula Treatment Market Attractiveness, by Region, 2018-2026
Figure 41: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 42: North America Anal Fistula Treatment Market Value Share, by Country, 2017 and 2026
Figure 43: North America Anal Fistula Treatment Market Attractiveness, by Country, 2018–2026
Figure 44: North America Anal Fistula Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 45: North America Anal Fistula Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 46: North America Anal Fistula Treatment Market Value Share, by Non-surgical Treatment, 2017 and 2026
Figure 47: North America Anal Fistula Treatment Market Attractiveness, by Non-surgical Treatment, 2018–2026
Figure 48: North America Anal Fistula Treatment Market Value Share, by Surgical Treatment, 2017 and 2026
Figure 49: North America Anal Fistula Treatment Market Attractiveness, by Surgical Treatment, 2018–2026
Figure 50: North America Anal Fistula Treatment Market Value Share Analysis, by Application
Figure 51: North America Anal Fistula Treatment Market Attractiveness, by Application, 2018–2026
Figure 52: North America Anal Fistula Treatment Market Value Share Analysis, by End-user
Figure 53: North America Anal Fistula Treatment Market Attractiveness, by End-user, 2018–2026
Figure 54: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 55: Europe Anal Fistula Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 56: Europe Anal Fistula Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 57: Europe Anal Fistula Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 58: Europe Anal Fistula Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 59: Europe Anal Fistula Treatment Market Value Share, by Non-surgical Treatment, 2017 and 2026
Figure 60: Europe Anal Fistula Treatment Market Attractiveness, by Non-surgical Treatment, 2018–2026
Figure 61: Europe Anal Fistula Treatment Market Value Share, by Surgical Treatment, 2017 and 2026
Figure 62: Europe Anal Fistula Treatment Market Attractiveness, by Surgical Treatment, 2018–2026
Figure 63: Europe Anal Fistula Treatment Market Value Share Analysis, by Application
Figure 64: Europe Anal Fistula Treatment Market Attractiveness, by Application, 2018–2026
Figure 66: Europe Anal Fistula Treatment Market Attractiveness, by End-user, 2018–2026
Figure 67: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 68: Asia Pacific Anal Fistula Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 69: Asia Pacific Anal Fistula Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 70: Asia Pacific Anal Fistula Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 71: Asia Pacific Anal Fistula Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 72: Asia Pacific Anal Fistula Treatment Market Value Share, by Non-surgical Treatment, 2017 and 2026
Figure 73: Asia Pacific Anal Fistula Treatment Market Attractiveness, by Non-surgical Treatment, 2018–2026
Figure 74: Asia Pacific Anal Fistula Treatment Market Value Share, by Surgical Treatment, 2017 and 2026
Figure 75: Asia Pacific Anal Fistula Treatment Market Attractiveness, by Surgical Treatment, 2018–2026
Figure 76: Asia Pacific Anal Fistula Treatment Market Value Share Analysis, by Application
Figure 77: Asia Pacific Anal Fistula Treatment Market Attractiveness, by Application, 2018–2026
Figure 78: Asia Pacific Anal Fistula Treatment Market Value Share Analysis, by End-user
Figure 79: Asia Pacific Anal Fistula Treatment Market Attractiveness, by End-user, 2018–2026
Figure 80: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 81: Latin America Anal Fistula Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 82: Latin America Anal Fistula Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 83: Latin America Anal Fistula Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 84: Latin America Anal Fistula Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 85: Latin America Anal Fistula Treatment Market Value Share, by Treatment Type (Non-surgical), 2017 and 2026
Figure 86: Latin America Anal Fistula Treatment Market Attractiveness, by Treatment Type (Non-surgical), 2018–2026
Figure 87: Latin America Anal Fistula Treatment Market Value Share, by Treatment Type (Surgical), 2017 and 2026
Figure 88: Latin America Anal Fistula Treatment Market Attractiveness, by Treatment Type (Surgical), 2018–2026
Figure 89: Latin America Anal Fistula Treatment Market Value Share Analysis, by Application
Figure 90: Latin America Anal Fistula Treatment Market Attractiveness, by Application, 2018–2026
Figure 91: Latin America Anal Fistula Treatment Market Value Share Analysis, by End-user
Figure 92: Latin America Anal Fistula Treatment Market Attractiveness, by End-user, 2018–2026
Figure 93: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 94: Middle East & Africa (MEA) Anal Fistula Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 95: Middle East & Africa (MEA) Anal Fistula Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 96: Middle East & Africa (MEA) Anal Fistula Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 97: Middle East & Africa (MEA) Anal Fistula Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 98: Middle East & Africa (MEA) Anal Fistula Treatment Market Value Share, by Treatment Type (Non-surgical), 2017 and 2026
Figure 99: Middle East & Africa (MEA) Anal Fistula Treatment Market Attractiveness, by Treatment Type (Non-surgical), 2018–2026
Figure 100: Middle East & Africa (MEA) Anal Fistula Treatment Market Value Share, by Treatment Type (Surgical), 2017 and 2026
Figure 101: Middle East & Africa (MEA) Anal Fistula Treatment Market Attractiveness, by Treatment Type (Surgical), 2018–2026
Figure 102: Middle East & Africa (MEA) Anal Fistula Treatment Market Value Share Analysis, by Application
Figure 103: Middle East & Africa (MEA) Anal Fistula Treatment Market Attractiveness, by Application, 2018–2026
Figure 104: Middle East & Africa (MEA) Anal Fistula Treatment Market Value Share Analysis, by End-user
Figure 105: Middle East & Africa (MEA) Anal Fistula Treatment Market Attractiveness, by End-user, 2018–2026
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
